References
- NIH Consensus Development Panel. Effect of corticosteroids for fetal maturation on perinatal outcomes. JAMA 1995; 273: 413–418
- Allen V M, Allen A C, Usher R H, Liston R M. The effect of multiple courses of maternal antenatal steroids on the preventions of complications of prematurity. Am J Obstet Gynecol 1997; 176: S48
- Abbasi S, Tolosa J, Debbs R, Grous M K, Gerdes J S. Effect of single versus serial courses of antenatal steroids on neonatal and maternal outcome. Pediatr Res 1997; 41: 135A
- Banks B A, Cnaan A, Planer B C, Parer J, Morgan M A, Ballard P L, Ballard R A, The North American T RH Study Group. Multiple courses of antenatal corticosteroids (ANCS): effect on respiratory morbidity, mortality and growth in preterm infants. Pediatr Res 1998; 43: 165A
- Liley H G, White R T, Warr R G, Benson B J, Hawgood S, Ballard P L. Regulation of messenger RNAs for the hydrophobic surfactant proteins in human lung. J Clin Invest 1989; 83: 1191–1197
- Ikegami M, Jobe A H, Newnham J, Polk D H, Willet K E, Sly P. Repetitive prenatal glucocorticoids improve lung function and decrease growth in preterm lambs. Am J Respir Crit Care Med 1997; 156: 178–184
- Jobe A, Wada N, Berry L M, Ikegami M, Ervin M G. Single and repetitive maternal glucocorticoid exposures reduce fetal growth in sheep. Am J Obstet Gynecol 1998; 178: 880–885
- Crowley P. Antenatal corticosteroid therapy: A meta-analysis of the randomized trials, 1972–1994. Am J Obstet Gynecol 1995; 173: 322–335
- Atkinson M W, Goldenberg R L, Gaudier F L, Cliver S P, Nelson K G, Merkatz I R. Maternal corticosteroid and tocolytic treatment and morbidity and mortality in very low birth weight infants. Am J Obstet Gynecol 1995; 173: 299–305
- Silver R K, Vyskocil C, Solomon S L, Ragin A, Neerhof M G, Farrell E E. Randomized trial of antenatal dexamethasone in surfactant-treated infants delivered before 30 weeks' gestation. Obstet Gynecol 1996; 87: 683–691
- Yoon B H, Romero R, Jun J K, Park K H, Park J D, Ghezzi F, Kim B I. Amniotic fluid cytokines (interleukin-6, tumor necrosis factor-alpha, interleukin-1 beta, and interleukin-8) and the risk for development of bronchopulmonary dysplasia. Am J Obstet Gynecol 1997; 177: 825–830
- Rebello C M, Ikegami M, Ervin M G, Polk D H, Jobe A H. Postnatal lung function and protein permeability after fetal or maternal corticosteroids in preterm lambs. J Appl Physiol 1997; 83: 213–218
- Bunton T E, Plopper C G. Triamcinolone-induced structural alterations in the development of the lung of the fetal rhesus macaque. Am J Obstet Gynecol 1984; 148: 203–215
- Polk D H, Ikegami M, Jobe A H, Sly P, Kohan R, Newnham J. Preterm lung function after retreatment with antenatal betamethasone in preterm lambs. Am J Obstet Gynecol 1997; 176: 308–315
- Garite T J, Rumney P J, Briggs G G, Harding J A, Nageotte M P, Towers C V, Freeman R K. A randomized placebo-controlled trial of betamethasone for the prevention of respiratory distress syndrome at 24 to 28 weeks' gestation. Am J Obstet Gynecol 1992; 166: 646–651
- Bauer C R, Morrison J C, Poole W K, Korones S B, Boehm J J, Rigatto H, Zachman R D. A decreased incidence of necrotizing enterocolitis after prenatal glucocorticoid therapy. Pediatrics 1984; 73: 682–688
- Italian multicentre study on retinopathy of prematurity. The Italian ROP Study Group. Eur J Pediatr 1997; 156: 939–943
- Inder T E, Clemen R S, Austin N C, Graham P, Darlow B A. High iron status in very low birth weight infants is associated with an increased risk of retinopathy of prematurity. J Pediatr 1997; 131: 541–544
- Mittal M, Dhanireddy R, Higgins R D. Candida sepsis and association with retinopathy of prematurity. Pediatrics 1998; 101: 654–657
- Yeh T F, Torre J A, Rastogi A, Anyebuno M A, Pildes R S. Early postnatal dexamethasone therapy in premature infants with severe respiratory distress syndrome. A double-blind, controlled study. J Pediatr 1990; 117: 273–282
- Papile L A, Stoll B, Donovan E, Tyson J, Bauer C, Wright L, et al. Dexamethasone therapy in infants at risk for chronic lung disease: a multi-center, randomized, double-masked trial. Pediatr Res 1996; 39: 236A
- Mercado A B, Wilson R C, Cheng K C, Wei J Q, New M I. Prenatal treatment and diagnosis of congenital adrenal hyperplasia owing to steroid 21-hydroxylase deficiency. J Clin Endocrinol Metab 1995; 80: 2014–2020
- Jones S A, Brooks A, Challis J RG. Steroids modulate corticotropin-releasing hormone production in human fetal membranes and placenta. J Clin Endocrinol Metab 1989; 68: 825–830
- Ghidini A, Salafia C M, Minior V K. Repeated courses of steroids in preterm membrane rupture do not increase the risk of histologic chorioamnionitis. Am J Perinatal 1997; 14: 309–313